The Fifth Circuit court’s ruling, which is being appealed, reinstates a requirement that patients visit a health care provider in person to obtain mifepristone, upending abortion access in the United States.
Go to Source
Author: Maggie Astor, Chris Hippensteel and Pam Belluck
https://rss.nytimes.com/services/xml/rss/nyt/HomePage.xml

